Home / Tag Archives: diabetes screening (page 2)

Tag Archives: diabetes screening

What Your Patient’s Skin May Be Telling You About Their Diabetes Risk

Healthcare provider examining a patient with visible diabetes skin manifestations, including acanthosis nigricans, diabetic dermopathy, and other dermatologic signs associated with diabetes risk and insulin resistance.

The skin is often described as a window into overall health, and in patients with diabetes or prediabetes, it may provide some of the earliest visible signs of underlying metabolic dysfunction. While laboratory testing remains the cornerstone of diabetes diagnosis, clinicians who recognize key skin manifestations of diabetes can identify …

Read More »

Diabulimia in Type 1 Diabetes: The Warning Signs Clinicians Often Miss

Young woman with type 1 diabetes appearing emotionally distressed beside diabetes supplies and healthy food, representing warning signs associated with diabulimia treatment challenges.

Patients with type 1 diabetes already face the daily burden of balancing insulin, food intake, exercise, and glucose monitoring. However, for some individuals, insulin becomes more than a treatment tool. It becomes a method for weight control. This dangerous behavior, commonly referred to as diabulimia, involves the intentional restriction or …

Read More »

Misdiagnosed as Type 2? Why We Need to Screen More Adults for LADA

Doctor explaining LADA diabetes screening to an adult patient previously diagnosed with type 2 diabetes during a clinical consultation.

Up to 10% of adults diagnosed with type 2 diabetes may actually have Latent Autoimmune Diabetes in Adults (LADA), yet many cases remain undetected for years. Because symptoms often develop slowly, LADA is frequently mistaken for traditional type 2 diabetes. However, the wrong diagnosis can delay insulin therapy, worsen glucose …

Read More »

The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?

Doctor reviewing a patient for possible diabetes misdiagnosis using diagnostic tools in a clinical setting

Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …

Read More »

Delaying Type 1 Diabetes Progression: What Long-Term Data Mean for Screening and Intervention

Immunotherapy vial with diabetes monitoring tools illustrating type 1 diabetes prevention and early intervention research

Can a chronic condition like type 1 diabetes be slowed before it fully develops? Recent long-term studies suggest that preventing or delaying type 1 diabetes may be closer to reality than once believed. In fact, emerging immunotherapy data is changing how clinicians view early-stage disease and the opportunity to intervene …

Read More »

Why Screening for Sleep Apnea Should Be Standard in Diabetes Care

A CPAP nasal mask and tubing placed beside diabetes and sleep apnea screening questionnaires, including the STOP-Bang tool.

In clinical practice, the link between sleep apnea diabetes screening and improved patient outcomes is becoming increasingly clear. Obstructive sleep apnea (OSA) is both a contributor to and a consequence of poor glycemic control, yet it remains under‑recognized in diabetes management. If clinicians fail to screen for sleep apnea in …

Read More »

The Expanding Landscape of Diabetes Complications: Liver Disease, Cancer, and Frailty

Illustration showing liver disease, cancer risk, brain health, and frailty in diabetes-related complications.

Early in training, many clinicians learn the classic “eye–kidney–foot” framework for recognizing and managing complications of diabetes. However, as science advances, the range of recognized consequences of diabetes—and opportunities for earlier intervention—continues to broaden. Today, the concept of diabetes complications screening must evolve to include conditions such as metabolic dysfunction–associated …

Read More »